IRF8

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA002267

Antibody HPA002531

Antibody CAB013480

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Moderate to strong nuclear immunoreactivity was observed in malignant lymphomas and some malignant gliomas. Remaining tumors were in general negative.Most malignant lymphomas showed strong nuclear staining, while some malignant melanomas displayed moderate cytoplasmic positivity. Remaining normal and malignant cells were in general weakly stained or negative.Colorectal cancers exhibited moderate nuclear positivity whereas strong nuclear immunoreactivity was observed in most malignant lymphomas and a few cases of gastric cancers. Remaining malignant cells were generally negative.

Validation

Supportive: Two (or more) antibodies yielding partly similar staining patterns which are consistent with gene/protein characterization data
Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data
Supportive: Two (or more) antibodies yielding partly similar staining patterns which are consistent with gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected